|
| Ashish K Khanna | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Kealy R Ham | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| James A Tumlin | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Harold M Szerlip | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| William W Busse | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Kenneth Krell | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Richard G Wunderink | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Marlies Ostermann | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Raghavan Murugan | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Michelle N Gong | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Balasubramanian Venkatesh | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Boyd Taylor Thompson | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Rinaldo Bellomo | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Jeff Jensen | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Stewart Kroll | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Lakhmir S Chawla | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| George F Tidmarsh | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |
| Adam M Deane | From Anesthesiology Institute, Center for Critical Care and Department of Outcomes Research, Cleveland Clinic, University of Ottawa, and the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Duke University Medical Center, NC (X.S.W.) Regions Hospital, MN (K.H.) University of Tennessee College of Medicine, Baylor University Medical Center, Emory University School of Medicine, Atlanta (L.W.B.) Inova Medical Center, University of California Davis School of Medicine, University of California Los Angeles, and La Jolla Pharmaceutical Company, Riverside Methodist Hospital, University of Maryland School of Medicine, Sunrise Hospital, Wellington Hospital, and Medical Research Institute of New Zealand, Eastern Idaho Regional Medical Center, Northwestern University Feinberg School of Medicine, King's College London, Guy's and St. Thomas' Hospital, University of Pittsburgh School of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, NY (M.N.G.) John Hunter Hospital, and School of Medicine and Public Health, University of Newcastle, Wesley Hospital and Princess Alexandra Hospital, University of Queensland, and School of Medicine, University of Melbourne, the Royal Melbourne Hospital, University of Melbourne (A.M.D.), University of Helsinki and Helsinki University Hospital, Helsinki (J.H.) INSERM UMR LIRIC (Lille Inflammation Research Center), Centre Hospitalier Universitaire Lille, Critical Care Center and University of Lille School of Medicine, Massachusetts General Hospital, Harvard Medical School |